Neoplasms

Showing NaN - NaN of 49

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumors Trial in Worldwide (GSK3901961, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Sep 15, 2023

Tumors Trial in Worldwide (GSK3845097, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Jul 5, 2023

Tumors, Lymphoma, Hematologic Tumors Trial in Ukraine, United States (TAK-981)

Recruiting
  • Neoplasms
  • +2 more
  • La Jolla, California
  • +15 more
Dec 7, 2022

Tumors Trial in Dallas, San Antonio, Toronto (GSK4381562, Dostarlimab)

Recruiting
  • Neoplasms
  • Philadelphia, Pennsylvania
  • +4 more
Nov 18, 2022

Tumors Trial in Worldwide (Dostarlimab)

Recruiting
  • Neoplasms
  • Dostarlimab
  • Birmingham, Alabama
  • +105 more
Nov 17, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Tumors Trial in Worldwide (Gene-modified (GM) T cell therapy)

Recruiting
  • Neoplasms
  • Gene-modified (GM) T cell therapy
  • Birmingham, Alabama
  • +173 more
Aug 1, 2022

Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

Terminated
  • Neoplasms
  • +27 more
  • Culver City, California
  • +28 more
Jul 25, 2022

Tumors Trial in Philadelphia (OTL38)

Completed
  • Neoplasms
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Jun 27, 2022

Tumors Trial in Worldwide (GSK3368715)

Terminated
  • Neoplasms
  • Los Angeles, California
  • +8 more
Mar 1, 2022

Tumors, Coronavirus Trial in United States

Recruiting
  • Neoplasms
  • Coronavirus
    • Birmingham, Alabama
    • +84 more
    Feb 23, 2022

    Ewing Sarcoma, Ewing Family of Tumors, Ewing's Tumor Metastatic Trial in United States (Vigil, Irinotecan, Temozolomide)

    Active, not recruiting
    • Ewing Sarcoma
    • +12 more
    • Vigil
    • +2 more
    • Little Rock, Arkansas
    • +16 more
    Feb 9, 2022

    Carcinoma, Endometrial Adenocarcinoma, Tumors Trial in United States (PEN-866 Sodium, fluorouracil, Folinic acid)

    Recruiting
    • Carcinoma
    • +18 more
    • PEN-866 Sodium
    • +3 more
    • Springdale, Arkansas
    • +15 more
    Feb 16, 2022

    Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

    Recruiting
    • Urothelial Carcinoma
    • +20 more
    • Gilbert, Arizona
    • +9 more
    Feb 3, 2022

    Tumors Trial in Worldwide (GSK adoptive cell therapy)

    Recruiting
    • Neoplasms
    • GSK adoptive cell therapy
    • Duarte, California
    • +37 more
    Feb 1, 2022

    Tumors, Cancer, Caregiver Trial in Philadelphia

    Recruiting
    • Neoplasms
    • +2 more
      • Philadelphia, Pennsylvania
        Cancer Support Community Research & Training Institute
      Jan 30, 2022

      Neuroblastoma, Neuroectodermal Tumors, Tumors Trial in United States (131I-MIBG, 131-MIBG + Vorinostat)

      Recruiting
      • Neuroblastoma
      • +2 more
      • San Francisco, California
      • +15 more
      Jan 7, 2022

      Tumors, Arteriovenous Malformation of CNS, Trigeminal Neuralgia Trial in Australia, Turkey, United States (SRS/SBRT)

      Recruiting
      • Neoplasms
      • +2 more
      • SRS/SBRT
      • Colorado Springs, Colorado
      • +24 more
      Jul 19, 2021

      Tumors Trial in Worldwide (GSK525762)

      Completed
      • Neoplasms
      • Little Rock, Arkansas
      • +14 more
      Apr 26, 2021

      Tumors Trial in Worldwide (Vemurafenib)

      Completed
      • Neoplasms
      • Rogers, Arkansas
      • +82 more
      Dec 11, 2020

      Ovarian Cancer, Tumors, Carcinoma Trial in Philadelphia (enzastaurin)

      Completed
      • Ovarian Cancer
      • +2 more
      • Philadelphia, Pennsylvania
        Gynecologic Oncology Group 215-854-0770
      Nov 24, 2020

      Malignant Glioma, Tumors Trial in Philadelphia (IGF-1R/AS ODN; Surgery with tissue harvest and implantation 20 diffusion

      Completed
      • Malignant Glioma
      • Neoplasms
      • IGF-1R/AS ODN; Surgery with tissue harvest and implantation 20 diffusion chambers in the rectus sheath with IGF-1R/AS ODN within 24 hours of craniotomy, implanted for 48 hours.
      • Philadelphia, Pennsylvania
        Thomas Jefferson University Hospital
      Oct 5, 2020

      Tumors Trial in United States (Lupartumab Amadotin (BAY1129980))

      Terminated
      • Neoplasms
      • Lupartumab Amadotin (BAY1129980)
      • La Jolla, California
      • +14 more
      Dec 9, 2019

      Tumors, Pituitary Tumors Trial in Philadelphia (OTL38)

      Terminated
      • Neoplasms
      • Pituitary Neoplasms
      • Philadelphia, Pennsylvania
        Hospital of the University of Pennsylvania
      Aug 2, 2019